Evidence map›Paper›PMID 33072095›Full record

ArticleFrontiers in immunology2020

Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.

Gantsetseg Tumurkhuu, Shuang Chen, Erica N Montano, Duygu Ercan Laguna, Gabriela De Los Santos, Jeong Min Yu, Malcolm Lane, Michifumi Yamashita, Janet L Markman, Luz P Blanco and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. When ISG15 is involved in inflammation.Frontiers in immunology · 2026
    Review
  4. Review
  5. 8-Oxoguanine: A Lesion, an Epigenetic Mark, or a Molecular Signal?International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. The molecular subtypes of autoimmune diseases.Computational and structural biotechnology journal · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Gantsetseg TumurkhuuDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Shuang ChenDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Erica N MontanoDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Duygu Ercan LagunaDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Gabriela De Los SantosDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Jeong Min YuDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Malcolm LaneDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Michifumi YamashitaDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Janet L MarkmanDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Luz P BlancoSystemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Mariana J KaplanSystemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.
Kenichi ShimadaDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Timothy R CrotherDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Mariko IshimoriDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Daniel J WallaceDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Caroline A JefferiesDivision of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Moshe ArditiDivision of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

Systemic AutoimmunityZIAAR041199 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KAPLAN, MARIANA · 2014 to 2025
$32.5M
Atherosclerosis in SLE - OGG-1 as a novel target for therapeutic interventionR21AI124211 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2016 to 2017
$481k
Intramural NIH HHS ZIA AR041199NIAID NIH HHS R21 AI124211
6 · The paper itself

Abstract

Systemic Lupus Erythematosus (SLE) is a chronic inflammatory autoimmune disease in which type I interferons (IFN) play a key role. The IFN response can be triggered when oxidized DNA engages the cytosolic DNA sensing platform cGAS-STING, but the repair mechanisms that modulate this process and govern disease progression are unclear. To gain insight into this biology, we interrogated the role of oxyguanine glycosylase 1 (OGG1), which repairs oxidized guanine 8-Oxo-2'-deoxyguanosine (8-OH-dG), in the pristane-induced mouse model of SLE.

Indexed as

AnimalsDisease Models, AnimalDNA DamageDNA GlycosylasesInflammationLupus Erythematosus, CutaneousLupus Erythematosus, SystemicMiceMice, KnockoutMonocytesOxidation-ReductionSkinTerpenesDNA GlycosylasesOgg1 protein, mousepristaneTerpenes8-OH-dGcGAS-STING pathwayIFN-stimulated genesOgg1SLE

Identifiers

PMID33072095
PMCPMC7541920
OpenAlexW3087948729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.